RehabCare Reports Results for Fourth Quarter and Fiscal Year 2009

By Benzinga Staff
March 02, 2010 4:12 PM

ST. LOUIS--(BUSINESS WIRE)--

RehabCare Group, Inc. (NYSE: RHB) today reported financial results for the quarter and year ended December 31, 2009. Comparative results for the quarter and year follow.


		Fourth			Third			Fourth			Year Ended
		Quarter			Quarter			Quarter			December 31,
	Amounts in millions, except per share data	2009			2009			2008				2009			2008

	Consolidated Operating Revenues	$	254.7		$	208.0		$	192.1		$	869.4		$	735.4
	Consolidated Operating Earnings (a) (b) (c)		6.9			10.5			9.5			44.5			32.9
	Consolidated Net Earnings from Continuing Operations		0.3			5.7			5.4			21.8			17.6
	Loss from Discontinued Operations, Net of Tax (d)		-			-			(0.3	)		(0.8	)		(0.9	)
	Consolidated Net Earnings		0.3			5.7			5.1			21.0			16.7
	Net Losses Attributable to Noncontrolling Interests		0.4			1.1			0.6			2.0			2.0
	Net Earnings Attributable to RehabCare		0.7			6.8			5.7			23.0			18.7
	Diluted Earnings per Share Attributable to RehabCare:
	Earnings from Continuing Operations, Net of Tax		0.03			0.37			0.34			1.26			1.10
	Net Earnings		0.03			0.37			0.32			1.22			1.05

	SRS Operating Revenues		126.0			123.4			118.1			496.3			457.2
	SRS Operating Earnings (a)		8.4			9.8			8.6			37.8			25.5
	SRS EBITDA		9.8			11.4			10.3			44.0			32.4

	HRS Inpatient Operating Revenues		33.3			32.9			32.4			130.9			122.8
	HRS Outpatient Operating Revenues		11.7			12.1			11.3			47.3			42.9
	HRS Operating Revenues		45.0			45.0			43.7			178.2			165.7
	HRS Operating Earnings (a) (b)		7.3			8.2			5.8			29.5			22.0
	HRS EBITDA		7.9			8.8			6.5			31.9			24.6

	Hospital Operating Revenues		83.8			39.7			30.3			195.0			112.5
	Hospital Operating Loss (a) (c)		(8.8	)		(7.6	)		(4.8	)		(22.5	)		(13.9	)
	Hospital EBITDA		(5.8	)		(5.9	)		(3.4	)		(14.7	)		(8.8	)

(a)	The fourth quarter and year ended December 31, 2009 includes certain transaction related pretax charges of $9.4 million, or $0.34 per diluted share (see table on page 11).
(b)	The fourth quarter and year ended December 31, 2008 includes a pretax charge arising from a bad debt write-down related to an outpatient transaction of $1.2 million, or $0.04 per diluted share after tax (see table on page 11).
(c)	Includes a pretax charge related to the cancellation of a planned acquisition in Providence, RI, and a long-term acute care hospital development project in Kokomo, IN, of $1.5 million, or $0.05 per diluted share after tax, in the quarter and year ended December 31, 2008 (see table on page 11).
(d)	The $0.8 million after-tax loss from discontinued operations in the year ended December 31, 2009 includes a $0.7 million after-tax loss on the sale of the Company’s Phase 2 Consulting business on June 1, 2009.

“Capping off a successful year of top and bottom line growth was our merger with Triumph HealthCare in November, which has rebalanced our business portfolio between managed and owned operations and given us extensive expertise across the post-acute continuum,” said John H. Short, Ph.D, RehabCare President and Chief Executive Officer. “The addition of Triumph has provided a new foundation for our Hospital operations to deliver strong, sustainable returns.

“Our outlook for the Skilled Nursing and Hospital Rehabilitation Services divisions underscores the strength of our contract services management team and effectiveness of our mitigation strategies in the face of challenging economic and regulatory conditions. In addition, our application of new technologies continues to differentiate our products and drive greater clinical and operational results.”

Financial Overview of Fourth Quarter

Consolidated operating revenues for the fourth quarter of 2009, including $39.7 million generated by Triumph HealthCare, were $254.7 million, a 32.6% increase compared to $192.1 million in the 2008 fourth quarter.

Consolidated net earnings attributable to RehabCare, including Triumph, were $0.7 million in the fourth quarter of 2009 compared to $5.7 million in the prior year quarter. Diluted earnings per share attributable to RehabCare for the fourth quarter of 2009 was $0.03, which included $7.2 million of certain after-tax charges, substantially all of which related to the Triumph merger (see table on page 11). Diluted earnings per share attributable to RehabCare for the 2008 fourth quarter was $0.32, including $1.7 million of after-tax charges. Excluding these charges, diluted earnings per share attributable to RehabCare was $0.37 in the fourth quarter of 2009 compared to $0.41 in the fourth quarter of 2008.

The 2009 fourth quarter also included $1.2 million after tax, or $0.06 per diluted share, in increased health insurance claim costs over the 2009 third quarter. As a result of being fully self-insured, the Company experiences quarter to quarter volatility in healthcare claim costs, but does not believe the increase in the fourth quarter represents a long-term trend.

Operating revenues in the Skilled Nursing Rehabilitation Services (SRS) division increased 6.7% from $118.1 million in the fourth quarter of 2008 to $126.0 million in the fourth quarter of 2009, driven by an increase in the average number of units operated and a contract therapy same store revenue increase of 4.6%. The division had a net gain of 50 units over year end 2008 and a net gain of 20 from the third quarter of 2009. On December 31, 2009, SRS operated in 1,118 locations compared to 1,068 locations at the end of the fourth quarter of 2008 and 1,098 locations at the end of the third quarter of 2009.

The SRS division’s operating earnings were $8.4 million, or 6.6% of revenue, compared to $8.6 million, or 7.3% of revenue, in the fourth quarter of 2008. Quarterly operating earnings margin was lower than the prior year primarily due to higher health insurance claim costs.

The Hospital Rehabilitation Services (HRS) division’s fourth quarter 2009 operating revenues increased 3.0% to $45.0 million, compared to $43.7 million in the fourth quarter of 2008. Inpatient operating revenues improved 2.8% and inpatient rehabilitation facility (IRF) same store revenues increased 2.1% compared to fourth quarter 2008. IRF same store discharges declined 0.8% over the prior year quarter, but increased 1.2% for the full year. The average number of inpatient programs declined by 4.2% while revenue per inpatient program increased 7.3% due to an improvement in contract mix compared to the year ago quarter. Outpatient operating revenues increased 3.5% in the 2009 fourth quarter versus the 2008 fourth quarter as same store revenues increased 5.6% and the average number of programs remained flat.

At December 31, 2009, HRS operated 145 programs compared to 157 at the end of the fourth quarter of 2008 and 154 at the end of the third quarter of 2009. The division operated 106 IRF programs at the end of the 2009 fourth quarter compared to 110 at the beginning of the quarter and 113 a year ago. The division had three IRF openings and seven IRF closings during the fourth quarter, including one related to a hospital closing and one contract terminated by RehabCare due to non-payment of services. HRS signed contracts for one subacute unit and one outpatient unit in the fourth quarter. At year end, the number of signed but unopened HRS contracts was seven, two of which were IRFs, compared to a backlog of five IRFs at the end of the third quarter. In response to lower contract signings, the Company is realigning its business development function and broadening its HRS product offerings to better serve the needs of the market.

HRS operating earnings were $7.3 million, or 16.3% of revenue, flat year over year when excluding a bad debt write-down in the 2008 fourth quarter.

Operating revenues in the legacy Hospital division for the fourth quarter of 2009 increased $4.4 million, or 11.1%, sequentially to $44.1 million. On a sequential basis, same store revenues and discharges increased 8.5% and 5.3%, respectively.

In 2009, the legacy Hospital division’s same store operating performance improved by $4.2 million, primarily a result of improved performance by the legacy long-term acute care hospitals (LTACHs). The legacy hospitals incurred a fourth quarter operating loss of $12.5 million, which included $8.4 million in transaction and severance expenses primarily related to the Triumph merger, $1.2 million in start-up losses for Greater Peoria Specialty Hospital and a $1.8 million operating loss at Dallas LTAC Hospital, where the operational turnaround has been slower than expected. The Company expects Dallas to be accretive by the end of the 2010 second quarter. Total year operating losses were $26.2 million for the legacy Hospital division, which included $11.8 million in transaction and severance related expenses and $4.8 million in start-up and ramp-up losses.

Triumph HealthCare, which was acquired on November 24, 2009, generated revenues of $39.7 million, operating earnings of $3.7 million and EBITDA (earnings before interest, taxes, depreciation and amortization) of $5.1 million during the first 37 days it was part of the Hospital division. November and December operating results for Triumph were impacted by softer acute care volumes, six hospitals achieving compliance with the 25-day length of stay requirement for LTACHs, the assimilation of the seven legacy RehabCare LTACHs into Triumph operations and the acquisition of St. Agnes Long-Term Care Hospital in Philadelphia, which was completed on December 16. The Company expects some continued impact from these issues through at least the first quarter of 2010.

With the acquisition of Triumph’s 20 LTACHs in November and St. Agnes in December, the combined division currently operates a total of 34 hospitals, including 28 LTACHs and six IRFs.

Balance Sheet and Liquidity

At December 31, 2009, the Company had $24.7 million in cash and cash equivalents and $464.2 million in outstanding debt excluding the impact of original issue discounts. Excluding Triumph, days sales outstanding decreased to 59.8 days at December 31, 2009 from 66.0 days at December 31, 2008.

For the year ended December 31, 2009, the Company generated cash from operations of $48.1 million and expended $13.2 million for capital expenditures, principally related to companywide information systems, equipment for the start-up of Greater Peoria Specialty Hospital, hospital facility maintenance capital and Triumph-related projects.

Legislative Update

With healthcare reform stalled in Congress, the Company is focused on securing extensions for both the Medicare Part B therapy cap exceptions process, which expired December 31, 2009, and the LTACH provisions contained in the 2007 Medicare, Medicaid and SCHIP Extension Act that are set to expire at the end of this year. The Company also is seeking resolution to a 21% cut in the Medicare physician fee schedule that occurred on March 1, 2010, and is optimistic that Congress will act on these issues in the near term. The Company remains engaged in the legislative process on these immediate concerns and other impending measures that could have adverse effects on Medicare beneficiaries, such as RUGs IV reimbursement and concurrent therapy rules slated to take effect October 1, 2010.

Outlook

The Company does not provide revenue and earnings per share guidance, but provides the following outlook for the total year 2010:

The Company anticipates strong consolidated revenue and net earnings growth for the full year, with progressively improving operating results throughout the year following softer performance in the first quarter.
The Skilled Nursing Rehabilitation Services division expects 6.5% to 7.5% operating earnings margins for the full year 2010, which will be driven by mid-single digit year-over-year same store revenue growth and which reflects an estimated impact of RUGs IV and concurrent therapy rules that go into effect October 1, 2010. First quarter 2010 results are expected to be impacted by Part B therapy caps, for which the Company has implemented an aggressive mitigation plan. The division also expects 50 to 75 net new units in 2010.
The Hospital Rehabilitation Services division expects 15% to 17% operating earnings margins and 2% to 4% year-over-year growth in IRF same store discharges for the full year 2010. Unit count is anticipated to decrease in the first half of the year and recover in the second half, resulting in flat unit growth for the total year 2010.
The Hospital division expects total year revenue of $650.0 to $675.0 million and EBITDA of $90.0 to $100.0 million. As previously stated, the Company expects a breakeven operating earnings run rate for its 13 legacy hospitals by the end of the second quarter of 2010 and to achieve breakeven operating earnings for the full year 2010.
The effective tax rate is anticipated to approximate 39% for 2010 after consideration of noncontrolling interests.
The Company expects continued strong operating cash flow with DSO in the range of 60 to 65 days.
Capital expenditures are anticipated to be $32.0 million in 2010, consisting of $12.5 million of information systems investments, $12.5 million in expansion projects and $7.0 million related to maintenance.

Closing Remarks

Dr. Short concluded, “While we expect implementation of the Part B therapy caps, lower HRS unit count and integration efforts to impact our performance in the first quarter, we are optimistic about the full year 2010 as we look to build on our strengths, fully integrate Triumph operations and continue to explore opportunities to expand our continuum of care.”

Conference Call Information

RehabCare will host a conference call on March 3, 2010, beginning at 10:00 AM Eastern time. Listeners may access the call by dialing (800) 640-9765, confirmation number 26277547, or in a listen-only mode through the Company’s website at http://www.rehabcare.com/about/investors/webcast.html. A replay of the call will be available beginning at approximately 2:00 PM Eastern Time on March 3 by dialing (877) 213-9653, confirmation number 26277547. An online archive of the conference call will remain on the Company’s website through April 2, 2010.

About RehabCare Group

Established in 1982 and headquartered in St. Louis, MO, RehabCare (www.rehabcare.com) is a leading provider of rehabilitation program management services in partnership with over 1,260 hospitals and skilled nursing facilities in 41 states. The Company also operates 34 freestanding long-term acute care and rehabilitation hospitals across the country. RehabCare is included in the Russell 2000 and Standard and Poor’s Small Cap 600 Indices.

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on the Company’s current expectations and could be affected by numerous factors, risks and uncertainties discussed in the Company’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. Do not rely on forward-looking statements as the Company cannot predict or control many factors that affect its ability to achieve the results estimated. The Company makes no promise to update any forward- looking statements because of changes in underlying factors, new information, future events or otherwise.


I. Condensed Consolidated Statements of Earnings
(Unaudited; amounts in thousands, except per share data)

	Three Months Ended									Year Ended
	Dec. 31,			Sept. 30,			Dec. 31,			Dec. 31,			Dec. 31,
		2009			2009			2008			2009			2008

Operating revenues	$	254,692		$	208,040		$	192,059		$	869,427		$	735,412
Costs and expenses:
Operating		209,562			170,020			155,554			704,394			597,879
Selling, general and administrative		33,138			23,813			23,284			104,060			90,056
Depreciation and amortization		5,120			3,727			3,710			16,499			14,570
Total costs and expenses		247,820			197,560			182,548			824,953			702,505

Operating earnings		6,872			10,480			9,511			44,474			32,907

Interest income		79			-			39			98			143
Interest expense		(3,927	)		(498	)		(745	)		(5,546	)		(3,897	)
Other income (expense), net		8			3			(3	)		12			21
Equity in net income of affiliates		105			52			30			431			471

Earnings from continuing operations before income taxes		3,137			10,037			8,832			39,469			29,645
Income tax expense		2,842			4,331			3,424			17,641			12,063
Earnings from continuing operations		295			5,706			5,408			21,828			17,582
Gain (loss) from discontinued operations		8			(16	)		(352	)		(839	)		(863	)
Net earnings		303			5,690			5,056			20,989			16,719
Net loss attributable to noncontrolling interests		352			1,067			647			1,966			1,986
Net earnings attributable to RehabCare	$	655		$	6,757		$	5,703		$	22,955		$	18,705

Amounts attributable to RehabCare:
Earnings from continuing operations	$	647		$	6,773		$	6,055		$	23,794		$	19,568
Gain (loss) from discontinued operations		8			(16	)		(352	)		(839	)		(863	)
Net earnings	$	655		$	6,757		$	5,703		$	22,955		$	18,705

Diluted EPS attributable to RehabCare:
Earnings from continuing operations	$	0.03		$	0.37		$	0.34		$	1.26		$	1.10
Gain (loss) from discontinued operations		-			-			(0.02	)		(0.04	)		(0.05	)
Net earnings	$	0.03		$	0.37		$	0.32		$	1.22		$	1.05

Weighted average diluted shares		21,284			18,282			17,855			18,862			17,798


II. Condensed Consolidated Balance Sheets
(Amounts in thousands)

	Unaudited
	December 31,		December 31,
	2009		2008
Assets
Cash and cash equivalents	$	24,690	$	27,373
Accounts receivable, net		199,447		139,197
Deferred tax assets		21,249		14,876
Other current assets		19,530		7,165
Total current assets		264,916		188,611

Property and equipment, net		111,814		37,851
Goodwill		566,078		171,365
Intangible assets		135,406		28,944
Investment in unconsolidated affiliate		4,761		4,772
Other assets		27,005		6,863
	$	1,109,980	$	438,406
Liabilities & Equity
Current portion of long-term debt	$	7,507	$	-
Payables & accruals		144,113		91,327
Total current liabilities		151,620		91,327

Long-term debt, less current portion		447,760		57,000
Other non-current liabilities		50,980		12,279
Stockholders’ equity		437,338		267,772
Noncontrolling interests		22,282		10,028
	$	1,109,980	$	438,406


III. Condensed Consolidated Statements of Cash Flows
(Unaudited; amounts in thousands)
	Year Ended
	December 31,
	2009			2008

Net cash provided by operating activities	$	48,090		$	48,658
Net cash used in investing activities		(557,851	)		(20,086	)
Net cash provided by (used in) financing activities		507,078			(11,464	)

Net (decrease) increase in cash and cash equivalents		(2,683	)		17,108
Cash and cash equivalents at beginning of period		27,373			10,265
Cash and cash equivalents at end of period	$	24,690		$	27,373


Supplemental information:
Additions to property and equipment	$	(13,215	)	$	(18,502	)


IV. Operating Statistics (Unaudited; dollars in thousands)


		Fourth			Third			Fourth		Year Ended
		Quarter			Quarter			Quarter		December 31,
		2009			2009			2008			2009			2008
Skilled Nursing Rehabilitation Services
Operating revenues	$	125,965		$	123,350		$	118,055		$	496,250		$	457,229
Operating expenses		103,698			99,631			95,443			402,461			373,939
Selling, general and administrative		12,448			12,321			12,322			49,753			50,911
Depreciation and amortization		1,463			1,564			1,677			6,283			6,835
Operating earnings	$	8,356		$	9,834		$	8,613		$	37,753		$	25,544
Operating earnings margin		6.6	%		8.0	%		7.3	%		7.6	%		5.6	%

EBITDA	$	9,819		$	11,398		$	10,290		$	44,036		$	32,379

Average number of contract therapy locations		1,121			1,089			1,076			1,088			1,066
End of period number of contract therapy locations		1,118			1,098			1,068			1,118			1,068

Patient visits (in thousands)		2,023			2,011			1,931			8,056			7,618


Hospital Rehabilitation Services
Operating revenues
Inpatient Rehabilitation Facility (IRF)	$	31,294		$	31,092		$	30,044		$	123,661		$	113,251
Subacute		1,981			1,834			2,327			7,202			9,559
Total Inpatient	$	33,275		$	32,926		$	32,371		$	130,863		$	122,810
Outpatient		11,691			12,113			11,291			47,305			42,848
Total HRS	$	44,966		$	45,039		$	43,662		$	178,168		$	165,658
Operating expenses		31,666			31,451			31,494			124,758			118,291
Selling, general and administrative		5,373			4,831			5,716			21,500			22,729
Depreciation and amortization		592			561			633			2,423			2,641
Operating earnings	$	7,335		$	8,196		$	5,819		$	29,487		$	21,997
Operating earnings margin		16.3	%		18.2	%		13.3	%		16.6	%		13.3	%

EBITDA	$	7,927		$	8,757		$	6,452		$	31,910		$	24,638

Average number of programs
IRF		110			111			112			112			109
Subacute		9			9			12			9			13
Total Inpatient		119			120			124			121			122
Outpatient		34			36			34			35			33
Total HRS		153			156			158			156			155

End of period number of programs
IRF		106			110			113			106			113
Subacute		9			9			9			9			9
Total Inpatient		115			119			122			115			122
Outpatient		30			35			35			30			35
Total HRS		145			154			157			145			157

IRF discharges		10,907			10,858			11,152			44,123			42,306
Outpatient visits (in thousands)		305			320			263			1,264			983


IV. Operating Statistics Continued (Unaudited; dollars in thousands)

		Fourth			Third			Fourth		Year Ended
		Quarter			Quarter			Quarter		December 31,
		2009			2009			2008			2009			2008
Hospitals
Operating revenues	$	83,761		$	39,651		$	30,342		$	195,009		$	112,525
Operating expenses		74,198			38,938			28,617			177,175			105,649
Selling, general and administrative		15,317			6,661			5,098			32,553			15,685
Depreciation and amortization		3,065			1,602			1,400			7,793			5,094
Operating earnings (loss)	$	(8,819	)	$	(7,550	)	$	(4,773	)	$	(22,512	)	$	(13,903	)
Operating earnings margin		-10.5	%		-19.0	%		-15.7	%		-11.5	%		-12.4	%

EBITDA	$	(5,754	)	$	(5,948	)	$	(3,373	)	$	(14,719	)	$	(8,809	)

RehabCare LTACHs
Number of hospitals – end of period		7			7			5			7			5
Available licensed beds – end of period		353			353			243			353			243
Admissions		752			775			442			2,564			1,723
Patient days		20,244			18,368			12,310			67,042			45,366
Average length of stay (Medicare days only)		27			24			28			26			26
Net inpatient revenue per patient day	$	1,238		$	1,157		$	1,138		$	1,205		$	1,097
Occupancy rate		62	%		60	%		55	%		63	%		56	%
Percent patient days - Medicare		72	%		66	%		74	%		72	%		77	%

Triumph LTACHs (for period 11/24/09 – 12/31/09)
Number of hospitals – end of period		21			-			-			21			-
Available licensed beds – end of period		1,240			-			-			1,240			-
Admissions		1,007			-			-			1,007			-
Patient days		27,221			-			-			27,221			-
Average length of stay (Medicare days only)		27			-			-			27			-
Net inpatient revenue per patient day	$	1,435			-			-		$	1,435			-
Occupancy rate		59	%		-			-			59	%		-
Percent patient days - Medicare		72	%		-			-			72	%		-

Combined LTACHs
Number of hospitals – end of period		28			7			5			28			5
Available licensed beds – end of period		1,593			353			243			1,593			243
Admissions		1,759			775			442			3,571			1,723
Patient days		47,465			18,368			12,310			94,263			45,366
Average length of stay (Medicare days only)		27			24			28			26			26
Net inpatient revenue per patient day	$	1,351		$	1,157		$	1,138		$	1,272		$	1,097
Occupancy rate		61	%		60	%		55	%		62	%		56	%
Percent patient days - Medicare		72	%		66	%		74	%		72	%		77	%

IRFs
Number of hospitals – end of period		6			6			6			6			6
Available licensed beds – end of period		243			243			243			243			243
Admissions		1,207			1,179			1,075			4,834			4,239
Patient days		15,923			15,202			14,036			61,719			52,770
Average length of stay (Medicare days only)		13			13			12			12			12
Net inpatient revenue per patient day	$	1,050		$	1,020		$	981		$	1,025		$	990
Occupancy rate		71	%		68	%		66	%		70	%		68	%
Percent patient days - Medicare		67	%		67	%		65	%		66	%		67	%


V. Operating Earnings and EBITDA Reconciliation

		Fourth			Third			Fourth		Year Ended
		Quarter			Quarter			Quarter		December 31,
		2009			2009			2008			2009			2008

SRS operating earnings	$	8,356		$	9,834		$	8,613		$	37,753		$	25,544
HRS operating earnings		7,335			8,196			5,819			29,487			21,997
Hospital operating earnings (loss)		(8,819	)		(7,550	)		(4,773	)		(22,512	)		(13,903	)
Unallocated items		-			-			(148	)		(254	)		(731	)
Consolidated operating earnings		6,872			10,480			9,511			44,474			32,907
Depreciation and amortization		5,120			3,727			3,710			16,499			14,570
Consolidated EBITDA	$	11,992		$	14,207		$	13,221		$	60,973		$	47,477


	VI. Charges Included in Statement of Earnings
	(Amounts in thousands, except per share data)

		Fourth Quarter 2009							Fourth Quarter 2008

		Pre-Tax Impact			After-Tax Impact		Diluted EPS		Pre-Tax Impact		After-Tax Impact		Diluted EPS

	Transaction expenses¹		$	7,070	$	4,313	$	0.20	$	-	$	-	$	-
	Tax impact of non-deductible transaction expenses²			-		1,502		0.07		-		-		-
	Severance expenses³			862		526		0.03		-		-		-
	Long-term incentive plan expense resulting from the transaction²			1,443		880		0.04		-		-		-
	Bad debt write-down related to an outpatient transaction			-		-		-		1,235		753		0.04
	Cancellation of planned acquisition in Rhode Island and an LTACH development project in Kokomo, IN			-		-		-		1,483		905		0.05
			$	9,375	$	7,221	$	0.34	$	2,718	$	1,658	$	0.09

	Breakdown by division
	Skilled Nursing Rehabilitation Services		$	648					$	-
	Hospital Rehabilitation Services			322						1,235
	Hospitals			8,405						1,483
			$	9,375					$	2,718

¹	$6,781 pretax related to the Triumph merger
²	Transaction expenses directly related to the Triumph merger
³	Severance expenses were primarily incurred in an effort to reduce corporate overhead and eliminate redundancies created by the Triumph merger